KMKarolina Michalska

Karolina Michalska

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Karolina Michalska has a total of 161 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A robotic and high-throughput X-ray micro-computed tomography workflow

    by Xiaoyang Liu, Alex Lavens, James Bennett O'SUllivan, Alan Kastengren, Andrew T. Townsend, Jason G. Toyoda, Hasitha Wijesuriya, Tamas Varga, Karolina Michalska

    With the recent upgrades of synchrotron facilities and an increasing demand for artificial intelligence (AI)-ready scientific datasets, there is a growing interest in high-throughput and automated experimental workflows to accelerate large-scale data-driven research. In this work, we demonstrate a fully automated data collection workflow for synchrotron micro-computed tomography experiment on soil cores on beamline 7-BM at the Advanced Photon Source (APS), operating without expert supervision. The automation integrates sample exchange, multi-position movement and data acquisition. A self-contained robotic arm system is designed for rapid and reliable sample exchange. It accommodates various sample types and can be readily deployed across multiple APS beamlines. Additionally, the beamline has recently upgraded the sample stage stacks to enable a large travel range and an efficient macroscope-based imaging system, enabling characterization of highly attenuating and large samples. This work establishes a foundation for future closed-loop, adaptive and intelligent synchrotron micro-computed tomography experiments.

  • Open Access

    PANCS-spec-Binders: A system for rapidly discovering isoform- or epitope-specific binders

    by Joshua A. Pixley, Matthew J. Styles, Kanokpol Aphicho, Micheal Endres, Priyanka Gade, Karolina Michalska, Andrzej Joachimiak, Bryan C. Dickinson

    Proteins that bind to a target protein of interest, termed “binders”, are essential components of biological research reagents and therapeutics. Target proteins present multiple binding surfaces with varying interaction potential. “Hot spots”, or high-potential surfaces, are experimentally identified as the most probable binding sites in de novo discovery campaigns. However, hot spots and their default binding modes do not always confer the desired specificity. Related proteins or isoforms often share similar hot spots, resulting in promiscuous binding. Interaction with a hot spot may also fail to elicit the intended biological outcome. Consequently, methods that direct de novo binder discovery toward targets with defined specificity are critically needed. We recently developed phage-assisted noncontinuous selection of binders (PANCS-Binders), a selection platform with unparalleled speed and sequence-function fidelity that enables routine de novo binder discovery within days. However, because PANCS-Binders selections enrich variants based primarily on affinity, secondary screening is unlikely to identify binders to lesser hot spots because of the high likelihood of convergence. These alternative binding surfaces with weaker inherent interactions may possess desirable specificity profiles. Here, we develop PANCS-spec-Binders, which incorporates simultaneous selection and counterselection to control the specificity of enriched binders. We demonstrate PANCS-spec-Binders in two proof-of-concept applications: 1) discovery of isoform-selective binders that bind HRAS with >100-fold higher affinity than the highly related KRAS isoform, and 2) discovery of epitope-specific binders that either target or avoid the LIR interaction region of LC3B. PANCS-spec-Binders enables rapid identification of binders with defined specificity within days.


  • eBERlight 101: Application of X-Ray Methods in Biological and Environmental Research Workshop (February 11–13, 2026)

    by Malgorzata Korbas, Xiaoyang Liu, Debora Meira, Qiaoling Jin, Karolina Michalska

    The eBERlight 101 Workshop, the second event of that annual series, was held February 11–13, 2026 at the Advanced Photon Source (APS), Argonne National Laboratory (ANL). The workshop provided an in...

  • Open Access

    Macromolecular Crystallography at the Upgraded Advanced Photon Source

    by Robert F. Fischetti, Laurent Chapon, Spencer M. Anderson, Joseph Brunzelle, Andrzej Joachimiak, Lisa J. Keefe, Karolina Michalska, Frank Murphy, Rama Ranganathan, John Rose, et al.

  • Open Access

    Revealing reaction intermediates in one-carbon elongation by thiamine diphosphate/CoA-dependent enzyme family

    by Youngchang Kim, Seung Hwan Lee, Priyanka Gade, Maren Nattermann, Natalia Maltseva, Michael Endres, Jing Chen, Philipp Wichmann, Yang Hu, Daniel G. Marchal, et al.

    2-Hydroxyacyl-CoA lyase/synthase (HACL/S) is a thiamine diphosphate (ThDP)-dependent versatile enzyme originally discovered in the mammalian α-oxidation pathway. HACL/S natively cleaves 2-hydroxyacyl-CoAs and, in its reverse direction, condenses formyl-CoA with aldehydes or ketones. The one-carbon elongation biochemistry based on HACL/S has enabled the use of molecules derived from greenhouse gases as biomanufacturing feedstocks. We investigated several HACL/S family members with high activity in the condensation of formyl-CoA and aldehydes, and distinct chain-length specificities and kinetic parameters. Our analysis revealed the structures of enzymes in complex with acyl-CoA substrates and products, several covalent intermediates, bound ThDP and ADP, as well as the C-terminal active site region. One of these observed states corresponds to the intermediary α–carbanion with hydroxymethyl-CoA covalently attached to ThDP. This research distinguishes HACL/S from related sub-families and identifies key residues involved in substrate binding and catalysis. These findings expand our knowledge of acyloin-condensation biochemistry and offer attractive prospects for biocatalysis using carbon elongation.


  • Open Access

    Revealing reaction intermediates in one-carbon elongation ThDP/CoA dependent enzyme family

    by Andrzej Joachimiak, Youngchang Kim, Seung Hwan Lee, Priyanka Gade, Maren Nattermann, Natalia Maltseva, Michael Endres, Jing Chen, Philipp Wichmann, Yang Hu, et al.

    2-Hydroxyacyl-CoA lyase/synthase (HACL/S) is a thiamine diphosphate (ThDP)-dependent versatile enzyme originally discovered in the mammalian α-oxidation pathway. HACL/S natively cleaves 2-hydroxyacyl-CoAs and, in its reverse direction, condenses formyl-CoA with aldehydes or ketones. The one-carbon elongation biochemistry based on HACL/S has enabled the use of molecules derived from greenhouse gases as biomanufacturing feedstocks. We investigated several HACL/S family members with high activity in the condensation of formyl-CoA and aldehydes, and distinct chain-length specificities and kinetic parameters. Our analysis revealed the structures of enzymes in complex with acyl-CoA substrates and products, several covalent transition states, bound ThDP and ADP, as well as a previously unseen C-terminal active site region. One of these new states corresponds to the intermediary α-carbanion with ThDP covalently attached to formyl- CoA. This research distinguishes HACL/S from related sub-families and identifies key residues involved in substrate binding and catalysis. These findings expand our knowledge of acyloincondensation biochemistry and offer new prospects for biocatalysis using carbon elongation.

  • Open Access

    Dual domain recognition determines SARS-CoV-2 PLpro selectivity for human ISG15 and K48-linked di-ubiquitin

    by Pawel M. Wydorski, Jerzy Osipiuk, Benjamin T. Lanham, Christine Tesar, Michael Endres, Elizabeth Engle, Robert Jedrzejczak, Vishruth Mullapudi, Karolina Michalska, Krzysztof Fidelis, et al.

    The Papain-like protease (PLpro) is a domain of a multi-functional, non-structural protein 3 of coronaviruses. PLpro cleaves viral polyproteins and posttranslational conjugates with poly-ubiquitin and protective ISG15, composed of two ubiquitin-like (UBL) domains. Across coronaviruses, PLpro showed divergent selectivity for recognition and cleavage of posttranslational conjugates despite sequence conservation. We show that SARS-CoV-2 PLpro binds human ISG15 and K48-linked di-ubiquitin (K48-Ub2) with nanomolar affinity and detect alternate weaker-binding modes. Crystal structures of untethered PLpro complexes with ISG15 and K48-Ub2 combined with solution NMR and cross-linking mass spectrometry revealed how the two domains of ISG15 or K48-Ub2 are differently utilized in interactions with PLpro. Analysis of protein interface energetics predicted differential binding stabilities of the two UBL/Ub domains that were validated experimentally. We emphasize how substrate recognition can be tuned to cleave specifically ISG15 or K48-Ub2 modifications while retaining capacity to cleave mono-Ub conjugates. These results highlight alternative druggable surfaces that would inhibit PLpro function.


  • Open Access

    Author Correction: Proteolytic processing induces a conformational switch required for antibacterial toxin delivery

    by Nicholas L. Bartelli, Victor J. Passanisi, Karolina Michalska, Kiho Song, Dinh Q. Nhan, Hongjun Zhou, Bonnie J. Cuthbert, Lucy M. Stols, William H. Eschenfeldt, Nicholas G. Wilson, et al.


  • Open Access

    Proteolytic processing induces a conformational switch required for antibacterial toxin delivery

    by Nicholas L. Bartelli, Victor J. Passanisi, Karolina Michalska, Kiho Song, Dinh Q. Nhan, Hongjun Zhou, Bonnie J. Cuthbert, Lucy M. Stols, William H. Eschenfeldt, Nicholas G. Wilson, et al.

    Many Gram-negative bacteria use CdiA effector proteins to inhibit the growth of neighboring competitors. CdiA transfers its toxic CdiA-CT region into the periplasm of target cells, where it is released through proteolytic cleavage. The N-terminal cytoplasm-entry domain of the CdiA-CT then mediates translocation across the inner membrane to deliver the C-terminal toxin domain into the cytosol. Here, we show that proteolysis not only liberates the CdiA-CT for delivery, but is also required to activate the entry domain for membrane translocation. Translocation function depends on precise cleavage after a conserved VENN peptide sequence, and the processed ∆VENN entry domain exhibits distinct biophysical and thermodynamic properties. By contrast, imprecisely processed CdiA-CT fragments do not undergo this transition and fail to translocate to the cytoplasm. These findings suggest that CdiA-CT processing induces a critical structural switch that converts the entry domain into a membrane-translocation competent conformation.


  • Open Access

    Fixed-target serial crystallography at the Structural Biology Center

    by Darren A. Sherrell, Alex Lavens, Mateusz Wilamowski, Youngchang Kim, Ryan Chard, Krzysztof Lazarski, Gerold Rosenbaum, Rafael Vescovi, Jessica L. Johnson, Chase Akins, et al.

    Serial synchrotron crystallography enables the study of protein structures under physiological temperature and reduced radiation damage by collection of data from thousands of crystals. The Structural Biology Center at Sector 19 of the Advanced Photon Source has implemented a fixed-target approach with a new 3D-printed mesh-holder optimized for sample handling. The holder immobilizes a crystal suspension or droplet emulsion on a nylon mesh, trapping and sealing a near-monolayer of crystals in its mother liquor between two thin Mylar films. Data can be rapidly collected in scan mode and analyzed in near real-time using piezoelectric linear stages assembled in an XYZ arrangement, controlled with a graphical user interface and analyzed using a high-performance computing pipeline. Here, the system was applied to two β-lactamases: a class D serine β-lactamase from Chitinophaga pinensis DSM 2588 and L1 metallo-β-lactamase from Stenotrophomonas maltophilia K279a.